CTI BIOPHARMA CORP
(12648L601)
Funds Reporting Holdings of CTI BIOPHARMA CORP according to 13F filings
Firm Name | Shares Held / Principal Amount | Market Value | Option | Report Period | Effectiveness Date |
---|---|---|---|---|---|
Orbimed Advisors LLC | 5,000,000 | $4,297k | Jun 30, 2019 | Aug 14, 2019 | |
Stonepine Capital Management LLC | 3,904,400 | $3,355k | Jun 30, 2019 | Aug 13, 2019 | |
Renaissance Technologies LLC | 1,596,587 | $1,372k | Jun 30, 2019 | Aug 12, 2019 | |
First Manhattan Co | 33 | $0k | Jun 30, 2019 | Aug 16, 2019 | |
Panagora Asset Management Inc | 206 | $0k | Jun 30, 2019 | Aug 9, 2019 |